Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis

Table 3 Differences in baseline values of patients in physician-perceived remission, stratified into patients in and not in self-perceived remission after 12 weeks of treatment

	In physician-perceived remission, n = 55
	In patient-perceived remission, n = 36	Not in patient-perceived remission, n = 19
DAS44	3.0 (1.1)	3.2 (1.0)
VAS global (mm)	47.5 [28.3–72.0]	66.0 [50.0–76.0]
TJC44ritchie	4.0 [3.0–9.0]	6.0 [4.0–11.0]
SJC44ritchie	6.0 [2.3–12.0]	6.0 [3.0–12.0]
ESR (mm/hour)	14.5 [8.0–31.0]	20.0 [12.0–40.0]
CRP (mg/l)	10.7 [4.2–24.8]	7.2 [3.9–32.0]
RAID pain	7.0 [3.0–8.0]	7.0 [4.8–8.0]
RAID FDA	6.0 [2.0–7.0]	5.0 [4.0–8.0]
RAID fatigue	5.0 [1.0–8.0]	6.0 [3.0–8.0]
RAID sleep	6.0 [2.0–8.0]	5.5 [2.0–7.3]
RAID physical well-being	3.0 [1.0–6.0]	3.5 [3.0–6.8]
RAID emotional well-being	3.0 [1.0–7.0]	4.0 [2.5–7.0]
RAID coping	3.0 [1.0–8.0]	5.0 [2.5–8.0]
HAQ	0.6 [0.1–1.1]	0.8 [0.4–1.5]

Numbers are presented as mean (SD) or median [IQR] where appropriate
CRP C-reactive protein, DAS44 disease activity score of 44 joints, ESR erythrocyte sedimentation rate, FDA functional disability assessment, HAQ Health Assessment Questionnaire, IQR interquartile range, l liter, mg milligram, mm millimeter, n number, RAID Rheumatoid Arthritis Impact of Disease questionnaire, SD standard deviation, SJC44 swollen joint count of 44 joints, TJC44 tender joint count of 44 joints, VAS visual analogue scale
*Significant difference (p < 0.05) in baseline values for patients in and not in self-perceived remission after 12 weeks of treatment

ISSN: 2520-1026